REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F957. A total of 13 filers reported holding REGENERON PHARMACEUTICALS in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,998 | +18.6% | 64,400 | +3.5% | 0.04% | +13.5% |
| Q2 2023 | $44,693 | -58.3% | 62,200 | -52.3% | 0.04% | -60.6% |
| Q1 2023 | $107,145 | +165.2% | 130,400 | +132.9% | 0.09% | +113.6% |
| Q4 2022 | $40,403 | -99.9% | 56,000 | -1.2% | 0.04% | 0.0% |
| Q3 2022 | $39,058,000 | -9.0% | 56,700 | -21.9% | 0.04% | -4.3% |
| Q2 2022 | $42,916,000 | +175.6% | 72,600 | +225.6% | 0.05% | +228.6% |
| Q1 2022 | $15,574,000 | -46.3% | 22,300 | -51.4% | 0.01% | -51.7% |
| Q4 2021 | $28,986,000 | +94.8% | 45,900 | +77.2% | 0.03% | +107.1% |
| Q3 2021 | $14,882,000 | +6.6% | 25,900 | +3.6% | 0.01% | +7.7% |
| Q2 2021 | $13,963,000 | – | 25,000 | +6620.4% | 0.01% | – |
| Q1 2021 | $0 | -100.0% | 372 | +1.9% | 0.00% | -100.0% |
| Q4 2020 | $17,633,000 | +36.4% | 365 | +58.0% | 0.02% | +27.8% |
| Q3 2020 | $12,930,000 | -46.1% | 231 | -40.0% | 0.02% | -52.6% |
| Q2 2020 | $24,010,000 | +2.4% | 385 | -19.8% | 0.04% | -7.3% |
| Q1 2020 | $23,437,000 | -33.5% | 480 | -48.8% | 0.04% | -46.8% |
| Q4 2019 | $35,220,000 | +123.9% | 938 | +65.4% | 0.08% | +71.1% |
| Q3 2019 | $15,728,000 | -45.0% | 567 | -37.9% | 0.04% | -42.3% |
| Q2 2019 | $28,576,000 | +69.3% | 913 | +122.1% | 0.08% | +66.0% |
| Q1 2019 | $16,876,000 | -25.1% | 411 | -31.8% | 0.05% | -28.8% |
| Q4 2018 | $22,522,000 | -27.2% | 603 | -21.3% | 0.07% | -33.3% |
| Q3 2018 | $30,949,000 | +42.4% | 766 | +21.6% | 0.10% | +16.5% |
| Q2 2018 | $21,734,000 | +1062.9% | 630 | -26.2% | 0.08% | +3.7% |
| Q1 2018 | $1,869,000 | +39.4% | 854 | -27.9% | 0.08% | +41.4% |
| Q4 2017 | $1,341,000 | -33.3% | 1,185 | +34.0% | 0.06% | -29.3% |
| Q3 2017 | $2,012,000 | +0.8% | 884 | -21.5% | 0.08% | -5.7% |
| Q2 2017 | $1,997,000 | -19.7% | 1,126 | +12.3% | 0.09% | -19.4% |
| Q1 2017 | $2,487,000 | +87.6% | 1,003 | -2.5% | 0.11% | +36.7% |
| Q4 2016 | $1,326,000 | +68.3% | 1,029 | +10.6% | 0.08% | +49.1% |
| Q3 2016 | $788,000 | -40.6% | 930 | +147.3% | 0.05% | -40.4% |
| Q2 2016 | $1,326,000 | -71.6% | 376 | +61.4% | 0.09% | -76.1% |
| Q1 2016 | $4,665,000 | +319.9% | 233 | -43.7% | 0.37% | +327.6% |
| Q4 2015 | $1,111,000 | -34.4% | 414 | +1.0% | 0.09% | -29.8% |
| Q3 2015 | $1,694,000 | +259.7% | 410 | +40.9% | 0.12% | +217.9% |
| Q2 2015 | $471,000 | -1.3% | 291 | -17.6% | 0.04% | -29.1% |
| Q1 2015 | $477,000 | +73.5% | 353 | -12.4% | 0.06% | +66.7% |
| Q4 2014 | $275,000 | – | 403 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 72,600 | $42,916,000 | 0.05% |
| JANE STREET GROUP, LLC | 74,600 | $44,098,000 | 0.02% |
| GROUP ONE TRADING, L.P. | 11,800 | $6,975,000 | 0.01% |
| HRT FINANCIAL LP | 700 | $413,000 | 0.01% |
| Allianz Asset Management GmbH | 1,500 | $887,000 | 0.00% |
| JPMORGAN CHASE & CO | 3,100 | $1,833,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |